NasdaqGM - Nasdaq Real Time Price USD
Third Harmonic Bio, Inc. (THRD)
5.20
-0.01
(-0.19%)
At close: May 20 at 4:00:00 PM EDT
5.20
0.00
(0.00%)
After hours: May 20 at 4:05:10 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
66,298
58,872
43,954
37,708
19,004
Operating Income
-66,298
-58,872
-43,954
-37,708
-19,004
Net Non Operating Interest Income Expense
12,864
13,409
13,108
2,555
--
Other Income Expense
-13
-6
22
-2
-10,605
Pretax Income
-53,447
-45,469
-30,824
-35,155
-29,609
Net Income Common Stockholders
-53,447
-45,469
-30,824
-35,155
-29,609
Diluted NI Available to Com Stockholders
-53,447
-45,469
-30,824
-35,155
-29,609
Basic EPS
-1.24
--
-0.78
-2.62
-0.80
Diluted EPS
-1.24
--
-0.78
-2.62
-0.80
Basic Average Shares
42,906.43
--
39,645.39
13,426.07
26,288.58
Diluted Average Shares
42,906.43
--
39,645.39
13,426.07
26,288.58
Total Operating Income as Reported
-66,298
-58,872
-43,954
-37,708
-19,004
Total Expenses
66,298
58,872
43,954
37,708
19,004
Net Income from Continuing & Discontinued Operation
-53,447
-45,469
-30,824
-35,155
-29,609
Normalized Income
-53,447
-45,469
-30,824
-35,155
-29,609
Interest Income
12,864
13,409
13,108
2,555
--
Net Interest Income
12,864
13,409
13,108
2,555
--
EBIT
-66,298
-58,872
-43,954
-37,708
-19,004
EBITDA
-66,248
-58,823
-43,919
-37,707
-19,004
Reconciled Depreciation
50
49
35
1
--
Net Income from Continuing Operation Net Minority Interest
-53,447
-45,469
-30,824
-35,155
-29,609
Normalized EBITDA
-66,248
-58,823
-43,919
-37,707
-19,004
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/14/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CRGX CARGO Therapeutics, Inc.
4.1000
+0.24%
PRTC PureTech Health plc
17.43
+3.74%
TYRA Tyra Biosciences, Inc.
9.98
+3.10%
PRTC.L PureTech Health plc
129.40
+1.09%
KROS Keros Therapeutics, Inc.
14.14
+0.28%
JBIO Jade Biosciences, Inc.
7.72
+3.98%
TCRX TScan Therapeutics, Inc.
1.2100
-2.42%
ACRV Acrivon Therapeutics, Inc.
1.2500
+5.93%
LENZ LENZ Therapeutics, Inc.
28.73
+0.98%
RLYB Rallybio Corporation
0.3458
-0.35%